HealthWeight Loss
Eli Lilly's Retatrutide: A Promising New Weight Loss Drug
Eli Lilly's next-generation drug, retatrutide, has demonstrated significant weight loss in a crucial late-stage trial for patients with obes...
22 days ago
HealthWeight Loss
Mounjaro Price Rise and Shortages Trigger Concern in the UK
10 months agoUS
The weight-loss drug Mounjaro is facing supply disruptions and significant price increases in the UK, causing concern among users and prompting potentially dangerous practices. This article examines the reasons behind the changes, the impact on patients, and expert advice on navigating the situation.
Key Insights
•
Price Hike:: Eli Lilly is increasing the UK list price of Mounjaro by up to 170% from September, potentially raising the cost of the highest dose from £122 to £330 per month. Why does this matter? This increase could make the drug unaffordable for many who rely on it for weight management.
•
Supply Disruptions:: Eli Lilly has paused shipments to UK wholesalers, leading to shortages as demand surges ahead of the price rise. Why does this matter? This disruption leaves patients scrambling and potentially turning to unsafe alternatives.
•
'Golden Dose' Concerns:: Some users are attempting to extract leftover medication from Mounjaro pens to create an extra dose, a practice experts warn against due to safety concerns. Why does this matter? This highlights the desperation of users and the potential health risks associated with improper drug administration.
•
NHS Access Unaffected:: The price increase will not affect those receiving Mounjaro through the NHS, as the service has negotiated its own discounted rate. Why does this matter? It ensures continued access for eligible patients with obesity and type 2 diabetes.
In-Depth Analysis
Background
Mounjaro (tirzepatide) has become a popular weight-loss drug in the UK, often used as an alternative to Ozempic. It works by making users feel full, reducing food intake and aiding in weight loss. Eli Lilly initially priced Mounjaro lower in the UK compared to other European markets to facilitate NHS access.
Reasons for the Price Increase
Eli Lilly cites the need to align UK prices with higher prices in Europe and the US. Additionally, pressure from the US government to lower drug prices in America has led to increased prices elsewhere.
Impact on Users
•
Cost:: Privately paying customers will face higher costs, potentially limiting access to the medication.
•
Availability:: Shortages are causing panic buying and restricted sales at pharmacies.
•
Safety:: Desperate users are attempting to extract extra doses from injection pens, risking inaccurate dosing and contamination.
Expert Advice
Olivier Picard, chairman of the National Pharmacy Association, advises against attempting to extract extra doses and urges users to consult with pharmacists for guidance. Pharmacies are working to support patients and explore options to minimize disruption to their treatment programs.
How to Prepare
•
Consult Your Pharmacist:: Discuss concerns and explore available options.
•
Understand Your Dosage:: Never attempt to alter or extract additional medication from injection pens.
•
Consider Alternatives:: If Mounjaro becomes unaffordable, discuss alternative weight-loss treatments with your healthcare provider.
Who This Affects Most
•
Individuals paying for Mounjaro privately.
•
Those who rely on Mounjaro for weight management before essential surgeries or fertility treatments.
FAQs
Why is Mounjaro's price increasing in the UK?
Eli Lilly is increasing prices to align with European and US markets and in response to pressure to lower drug prices in the US.
Will the price increase affect those receiving Mounjaro through the NHS?
No, the NHS has negotiated a discounted rate, ensuring continued access for eligible patients.
What is the 'golden dose,' and is it safe to extract it?
The 'golden dose' refers to leftover medication in Mounjaro pens. Experts strongly advise against extracting it due to potential safety risks.
Key Takeaways
•
Mounjaro users in the UK face rising prices and supply shortages.
•
Attempting to extract extra doses from injection pens is dangerous and not recommended.
•
The NHS will continue to provide Mounjaro at a discounted rate for eligible patients.
•
Consult with your pharmacist or healthcare provider to explore safe and affordable weight-loss options.
Discussion
Do you think these price increases and shortages will significantly impact weight management efforts in the UK? Let us know in the comments below!
Share this article with others who need to stay ahead of this trend!
Related Articles
HealthWeight Loss
Natural Ozempic Alternative Discovered by Stanford Scientists
A groundbreaking discovery by Stanford Medicine has identified a natural molecule, dubbed BRP, that mirrors the weight loss benefits of sema...
about 2 months ago
HealthWeight Loss
Jillian Michaels and Megyn Kelly Open Up About Their Health Journeys
Staying healthy involves consistent effort and the journey looks different for everyone. Jillian Michaels and Megyn Kelly have recently shar...
2 months ago
HealthWeight Loss
Wegovy Maker Challenges Weight-Loss Drug Copycats Amidst Telehealth Boom
The market for weight-loss drugs is heating up as Novo Nordisk, the maker of Wegovy, takes legal action against telehealth companies like Hi...
4 months ago
⚠ Disclaimer: Yanuki provides article summaries and links for reference only. Yanuki does not endorse, verify, or guarantee the accuracy of third-party sources. Please review original sources and verify information independently. Managed by the Yanuki Data Engine. Full Disclaimer